TABLE 2.
Top 10 co-cited publications and journals on inflammatory tumor microenvironment.
| Rank | Count | Centrality | Publication | Year | Count | Centrality | Journal | JCR |
|---|---|---|---|---|---|---|---|---|
| 1 | 250 | 0.02 | Hallmarks of Cancer: The Next Generation, Hanahan and Weinberg (2011) | 2011 | 2,889 | 0.03 | Cancer Research | Q1 |
| 2 | 135 | 0.01 | Immunity, Inflammation, and Cancer, Grivennikov et al. (2010) | 2010 | 2,540 | 0.02 | Nature | Q1 |
| 3 | 131 | 0.00 | Global Cancer Statistics 2018 GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, Bray et al. (2018) | 2018 | 2,358 | 0.02 | Proceedings of the National Academy of Sciences of the United States | Q1 |
| 4 | 123 | 0.02 | Cancer-Related Inflammation, Mantovani et al. (2008) | 2008 | 2,319 | 0.01 | Cell | Q1 |
| 5 | 91 | 0.02 | Myeloid-Derived Suppressor Cells as Regulators of the Immune System, Gabrilovich and Nagaraj (2009) | 2009 | 2,163 | 0.01 | Clinical Cancer Research | Q1 |
| 6 | 89 | 0.03 | Coordinated Regulation of Myeloid Cells by Tumors, Gabrilovich et al. (2012) | 2012 | 2,069 | 0.02 | Journal of Immunology | Q2 |
| 7 | 81 | 0.04 | Tumor-Associated Macrophages: From Mechanisms to Therapy, Noy and Pollard (2014) | 2014 | 2,051 | 0.01 | Nature Reviews Cancer | Q1 |
| 8 | 79 | 0.04 | Recommendations for Myeloid-Derived Suppressor Cell Nomenclature and Characterization Standards, Bronte et al. (2016) | 2010 | 2,027 | 0.01 | Plos One | Q2 |
| 9 | 79 | 0.03 | Macrophage Diversity Enhances Tumor Progression and Metastasis, Qian and Pollard (2010) | 2016 | 1,948 | 0.01 | Journal of Clinical Investigation | Q1 |
| 10 | 78 | 0.00 | Cancer Statistics 2019, Siegel et al. (2019) | 2019 | 1,893 | 0.01 | Cancer Cell | Q1 |